 | | PRD_002610 | | Name: | TELAPREVIR, unbound form | | Formula: | C36 H53 N7 O6 | | Definition date: | 2026-06-03 | | Last modified: | 2026-06-03 |
|
 | | PRD_002603 | | Name: | manikomycin (MKM) | | Formula: | C50 H86 N22 O12 | | Description: | Cyclic depsipeptide | | Definition date: | 2026-05-27 | | Last modified: | 2026-05-27 |
|
 | | PRD_002606 | | Name: | peptide PA1-A | | Formula: | C40 H55 N7 O7 | | Definition date: | 2026-05-27 | | Last modified: | 2026-05-27 |
|
 | | PRD_002607 | | Name: | peptide PA9 | | Formula: | C41 H51 N7 O7 | | Definition date: | 2026-05-27 | | Last modified: | 2026-05-27 |
|
 | | PRD_002609 | | Name: | peptide PA5 | | Formula: | C41 H57 N7 O7 | | Definition date: | 2026-05-27 | | Last modified: | 2026-05-27 |
|
 | | PRD_002577 | | Name: | AF23 peptide | | Formula: | C26 H33 F3 N8 O6 | | Definition date: | 2026-05-20 | | Last modified: | 2026-05-20 |
|
 | | PRD_002579 | | Name: | AF27 Peptide | | Formula: | C27 H36 F3 N7 O4 | | Definition date: | 2026-05-20 | | Last modified: | 2026-05-20 |
|
 | | PRD_002589 | | Name: | methyl 2'-fluoro-N-acetyllactosaminide | | Formula: | C15 H26 F N O10 | | Description: | fluorinated analogue of methyl N-acetyllactosaminide | | Definition date: | 2026-05-06 | | Last modified: | 2026-05-06 |
|
 | | PRD_002602 | | Name: | N-(trifluoroacetyl)-D-phenylalanyl-N-{(1Z,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-phenylalaninamide | | Formula: | C27 H30 F3 N5 O4 | | Definition date: | 2026-04-22 | | Last modified: | 2026-04-22 |
|
 | | PRD_002593 | | Name: | Glutathione | | Formula: | C10 H17 N3 O6 S | | Definition date: | 2026-03-04 | | Last modified: | 2026-03-04 |
|
 | | PRD_002590 | | Name: | methyl 6-fluoro-N-acetyllactosaminide | | Formula: | C15 H26 F N O10 | | Description: | fluorinated analogue of methyl N-acetyllactosaminide | | Definition date: | 2026-02-18 | | Last modified: | 2026-02-18 |
|
 | | PRD_002597 | | Name: | Microcolin H | | Formula: | C38 H65 N5 O9 | | Description: | Modified polypeptide capped either side by variable UNK residues. UNK -methylated Leucine - Acetylated Threonine - Methylated Valine - Hydroxylated proline - UNK | | Definition date: | 2026-02-04 | | Last modified: | 2026-02-04 |
|
 | | PRD_002585 | | Name: | peptide Ra30303 | | Formula: | C103 H134 N21 O24 S2 | | Definition date: | 2025-12-24 | | Last modified: | 2025-12-24 |
|
 | | PRD_002591 | | Name: | B Lewis b | | Formula: | C32 H55 N O24 | | Description: | Oligosaccharide with branches | | Definition date: | 2025-10-29 | | Last modified: | 2025-10-29 |
|
 | | PRD_002584 | | Name: | Lacto-N-biose I | | Formula: | C14 H25 N O11 | | Description: | An amino disaccharide consisting of beta-D-galactose (GAL) linked via a (1-3)-glycosidic bond to N-acetyl-D-glucosamine (NDG). | | Definition date: | 2025-07-02 | | Last modified: | 2025-07-02 |
|
 | | PRD_000180 | | Name: | N-carboxyphenylalanyl-N~5~-[amino(iminio)methyl]ornithyl-N-[(2S)-5-carbamimidamido-1-hydroxypentan-2-yl]-L-valinamide | | Formula: | C27 H47 N10 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2025-06-16 |
|
 | | PRD_002569 | | Name: | Rufomycin analog | | Formula: | C58 H87 Cl N9 O12 | | Definition date: | 2025-04-16 | | Last modified: | 2025-04-16 |
|
 | | PRD_002534 | | Name: | Inhibitor YBX-PHE-VAL-GLY-THR-THR-PHA-MAA-BIF-EME-NEH | | Formula: | C64 H84 N10 O14 S | | Definition date: | 2025-03-26 | | Last modified: | 2025-03-26 |
|
 | | PRD_002560 | | Name: | Entolysin A | | Formula: | C81 H141 N17 O23 | | Description: | D-Ser, L-Val, L-Leu, D-Ser, L-Ile amino acids make up a macrocycle within the peptide | | Definition date: | 2025-02-26 | | Last modified: | 2025-02-26 |
|
 | | PRD_002561 | | Name: | Orfamide A | | Formula: | C64 H114 N10 O17 | | Description: | Cyclic lipopeptide | | Definition date: | 2025-02-26 | | Last modified: | 2025-02-26 |
|
 | | PRD_002568 | | Name: | Fluorinated GM1 ganglioside analogue | | Formula: | C49 H84 F2 N2 O27 | | Description: | GM1 ganglioside lipids (monosialotetrahexosylgangliosides) belong to the group of gangliosides within the sphingolipids. Their structure consists of a ceramide backbone linked to an oligosaccharide unit made of five sugar molecules. In this analogue one of the five sugars is fluorinated and the ceramide backbone is replaced by an unsaturated hydrocarbon. | | Definition date: | 2025-02-26 | | Last modified: | 2025-02-26 |
|
 | | PRD_002573 | | Name: | Sialyl-Tn-Ser | | Formula: | C22 H37 N3 O16 | | Description: | Sialyl-Tn (sTn) antigen is a truncated O-glycan containing a sialic acid alpha-2,6 linked to N-acetylgalactosamine (GalNAc) alpha-O-serine or to N-acetylgalactosamine (GalNAc) alpha-O-threonine. | | Definition date: | 2025-02-12 | | Last modified: | 2025-02-12 |
|
 | | PRD_002574 | | Name: | Sialyl-Tn-Thr | | Formula: | C23 H39 N3 O16 | | Description: | Sialyl-Tn (sTn) antigen is a truncated O-glycan containing a sialic acid alpha-2,6 linked to N-acetylgalactosamine (GalNAc) alpha-O-threonine or to N-acetylgalactosamine (GalNAc) alpha-O-serine. | | Definition date: | 2025-02-12 | | Last modified: | 2025-02-12 |
|
 | | PRD_002460 | | Formula: | C20 H39 N3 O5 | | Description: | Calpain I inhibitor | | Definition date: | 2021-02-24 | | Last modified: | 2025-02-04 |
|
 | | PRD_002363 | | Formula: | C73 H120 N20 O13 | | Definition date: | 2020-08-12 | | Last modified: | 2025-02-04 |
|
